Tag: drug pricing

Upcoming patent expirations for top biologics like Keytruda and Humira will unleash a wave of biosimilars, slashing drug costs by up to 35%. Learn how these complex alternatives work, why adoption is slow in the U.S., and what it means for patients and healthcare spending.